Navigation Links
Edwards' Resilient Trial Demonstrates Statistically Superior Results for Treating Peripheral Arterial Disease in the Leg
Date:10/23/2007

self-expanding stent as an alternative for patients evaluating treatment options for SFA disease," said co-principal investigator John R. Laird, M.D., Medical Director of the Vascular Center at the University of California, Davis Medical Center. "Millions of patients suffering from PAD are in need of a clinically proven therapy that will improve their quality of life, allow them to be more active and walk without pain."

"We are very pleased with the 12-month results of The RESILIENT Trial, which provide clinicians with the highest level of clinical data available for a therapy to treat PAD patients less invasively," said Stuart L. Foster, Edwards' corporate vice president, Critical Care and Vascular.

The LifeStent self-expanding nitinol stent is a percutaneously-delivered flexible mesh tube that expands when deployed to prop open a diseased vessel and is specifically designed to withstand bending and twisting of the SFA. In 2004, Edwards initiated The RESILIENT Trial enrolling 246 patients at 25 sites, including 134 LifeStent self-expanding stent patients randomized against 72 balloon angioplasty patients.

The SFA is the major artery providing blood flow to the leg and extends behind the knee as the popliteal artery. This is a common area of blockage, or significant narrowing of the artery, in patients who suffer from atherosclerosis of the lower extremities, causing moderate to severe pain due to poor blood flow in the leg muscles. It is estimated that approximately 8 million Americans suffer from lower-extremity PAD, which affects mostly men and women older than 50 years. Without an effective treatment, PAD can develop into critical limb ischemia, a severe obstruction of the arteries with decreased blood flow to the lower extremities that may result in amputation.

Edwards is currently in discussions with the U.S. Food and Drug Administration (FDA) for premarket approval of its LifeStent system with an SFA indication.

About Edwards Li
'/>"/>

SOURCE Edwards Lifesciences Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
2. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
3. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
4. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
5. Gene Therapy Eradicates Pancreatic Cancer in Preclinical Trial Targeting Systems Success in Mouse Model Reported in Cancer Cell
6. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
7. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
8. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
9. TransPharma Medical Announces Positive Results of Phase I Clinical Trials for Transdermal Delivery of hPTH (1-34) for Osteoporosis Treatment
10. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
11. MediGene Announces Cancer-Fighting Virus Shows Promise in Early Clinical Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... 30, 2015  Cleveland Clinic President Wael Barsoum ... last month that industry is compelled to adopt declining ... the efficiencies—and develop the transformational innovations -- required to ... were preceded by Doug Kohrs , past President ... who stressed that industry must add "episode of care," ...
(Date:7/30/2015)... 30, 2015 Future Market Insights ... "Continuous Glucose Monitoring Systems Market: Global Industry Analysis and ... the global continuous glucose monitoring systems market was valued ... to reach US$ 788.4 Mn by 2020, registering a ... 2020. Global continuous glucose monitoring systems market ...
(Date:7/30/2015)... Takeda Pharmaceutical Company Limited ("Takeda") today announced ... post-marketing commitment and submissions of data to regulatory ... Cancer Risk Characterization Study , a large (n= ... four European countries, for pioglitazone containing medicines, including ... of follow-up. Findings demonstrate that there is no ...
Breaking Medicine Technology:Orthopaedic Surgery Reimbursement Shifts to Episode of Care 2Global Continuous Glucose Monitoring (CGM) Systems Market: Transmitters and Monitors Most Dominant Segment, Says Future Market Insights 2Global Continuous Glucose Monitoring (CGM) Systems Market: Transmitters and Monitors Most Dominant Segment, Says Future Market Insights 3Global Continuous Glucose Monitoring (CGM) Systems Market: Transmitters and Monitors Most Dominant Segment, Says Future Market Insights 4Takeda Announces Completion of the Pioglitazone Post-Marketing Commitment and Submission of Results to the EMA, the FDA and the PMDA 2Takeda Announces Completion of the Pioglitazone Post-Marketing Commitment and Submission of Results to the EMA, the FDA and the PMDA 3Takeda Announces Completion of the Pioglitazone Post-Marketing Commitment and Submission of Results to the EMA, the FDA and the PMDA 4Takeda Announces Completion of the Pioglitazone Post-Marketing Commitment and Submission of Results to the EMA, the FDA and the PMDA 5Takeda Announces Completion of the Pioglitazone Post-Marketing Commitment and Submission of Results to the EMA, the FDA and the PMDA 6
... PDS Biotechnology Corporation today,announced that the company ... the US,National Cancer Institute,s Nanotechnology Characterization Lab ... to filing of,the Investigational New Drug Application. ... biological studies on behalf of the company ...
... Dendreon Corporation (Nasdaq:,DNDN) today will present a summary ... investigational active cellular immunotherapy, at the,Chemotherapy Foundation Symposium ... data from two clinical trials, highlights the safety,profile, ... patients with,HER2/neu-positive cancer who have failed standard therapy., ...
Cached Medicine Technology:PDS Biotechnology Corporation Progresses Development of Nanotechnology Cancer Therapies 2Dendreon Presents Integrated Analysis of Clinical Data from NEUVENGE Trials at Chemotherapy Foundation Symposium 2Dendreon Presents Integrated Analysis of Clinical Data from NEUVENGE Trials at Chemotherapy Foundation Symposium 3Dendreon Presents Integrated Analysis of Clinical Data from NEUVENGE Trials at Chemotherapy Foundation Symposium 4
(Date:7/31/2015)... ... 2015 , ... Super-Sod wants to participate in planning new home lawns from ... the perfect fit for such a goal. Houzz is a social media site that ... dynamic site that spreads home and home garden design ideas when members share their ...
(Date:7/31/2015)... ... 2015 , ... India Network Foundation sponsors visitor health insurance program ... visit for the past 25 years. As India Network offers coverage for all age ... spend time with their children and grand children. India Network specializes in covering ...
(Date:7/31/2015)... ... July 31, 2015 , ... With the recent buzz surrounding ... who remain undiagnosed, treatment options for patients are becoming more prevalent than ever ... due to its overall lack of comfort and highly invasive nature, oral appliances ...
(Date:7/30/2015)... Islands, BWI (PRWEB) , ... July 31, 2015 , ... The Venetian on Grace Bay ... 2015. Guests who stay at the Venetian will save 40% on their stay while ... months are always quiet in the Turks & Caicos, providing a chance to reconnect with ...
(Date:7/30/2015)... ... July 30, 2015 , ... As more hospitals across the country see the ... a serious challenge. Because of growing competition, it is more important than ever ... , The team at Wound Care Advantage has found that while ...
Breaking Medicine News(10 mins):Health News:Super-Sod Created a Landscape Profile on Houzz.com for Home Garden Design 2Health News:India Network Visitor Health Insurance Announces Completion of Food Grains Distribution to Godavari Pushkaram Visitors, Andhra Pradesh, India 2Health News:India Network Visitor Health Insurance Announces Completion of Food Grains Distribution to Godavari Pushkaram Visitors, Andhra Pradesh, India 3Health News:Oravan Sleep Apnea Device Gains Traction in Sleep Industry 2Health News:The Venetian on Grace Bay in Turks & Caicos Islands Offers 40% Savings This Fall. 2Health News:WCA Offers Shockwave; The Marketing Module for Hospital Wound Care Programs 2Health News:WCA Offers Shockwave; The Marketing Module for Hospital Wound Care Programs 3Health News:WCA Offers Shockwave; The Marketing Module for Hospital Wound Care Programs 4
... life, chronic diseases and other health problems tend to accumulate ... in the latest issue of The Journal of Gerontology: Medical ... to the presence of coexisting medical conditions - known as ... articles on the topic. ,New diagnoses of common ...
... recent study finds that stents do not prevent heart ... minimize chest pains and to prevent heart attacks//. Stents ... keep them open. ,This landmark study funded ... stents do improve blood flow but are no more ...
... for its abundant health benefits. Now, British scientists, armed ... of a vital element in green tea, which may ... in the Journal of Allergy and Clinical Immunology. ... discovered that an important element in green tea called ...
... has shown the increase in the number of licenses ... Physicians// and Surgeons- 42 per cent of the 2,961 ... graduates. ,Among the foreign-trained doctors who received ... the rest were enabled education licenses or positions for ...
... the Federal Government’s decision to include the rotavirus vaccine // ... past year, the AMA has been calling for the Government ... at risk of contracting the deadly disease, so we’re very ... Australian babies,” Dr Haikerwal said. ,“Rotavirus is ...
... The killer or killers of cricket coach Bob Woolmer used ... absence of any marks on his neck, newspaper reports from ... introducing many modern techniques in coaching, was found unconscious in ... less than 24 hours after Pakistan was knocked out of ...
Cached Medicine News:Health News:Stents Do Little to Prevent Heart Attacks 2Health News:Bob Woolmer Was Strangled With A Towel 2
... IMMULITE 2500 is a high-throughput immunoassay system ... the IMMULITE 2000 with the important addition ... ,allows assays to be designed for optimal ... ,This allows for critical assays such as ...
The Acute Care myoglobin method is an in vitro diagnostic test for the measurement of myoglobin in heparinized whole blood /plasma. Myoglobin measurements can be used as an aid in diagnosing myocardi...
... Today's three preferred cardiac markers ... Aio! immunoassay system. Cardiac Troponin ... with very high sensitivity and ... Myoglobin appears very soon following ...
... the quantitative determination of myoglobin concentration in ... test is based on the principle of ... assay system utilizes a unique monoclonal antibody ... the myoglobin molecule. Mouse monoclonal anti-myoglobin antibody ...
Medicine Products: